Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have painful, treatment-resistant nerve damage in the hands, feet, or other distant parts of the limbs — ideally caused by an injury or surgery — that has been confirmed by a nerve and muscle electrical test (called an EMG)
- People whose pain has not responded to standard medical treatments for at least 6 months, as determined by their treating doctor
- People aged 18 or older
- People whose average pain level in the week before assessment is rated at least 5 out of 10 on a pain scale
- People whose pain medication is either not being used or has been on a stable dose (confirm with trial site)
Who may not be able to join:
- People whose nerve damage is located in the head or torso rather than the limbs
- People whose nerve damage is caused by a specific type of nerve root tearing at the shoulder nerve network (called brachial plexus avulsion)
- People with a life expectancy of less than one year
- People who are on blood-thinning medications or who have a condition that affects blood clotting
- People with a weakened immune system
- People who are pregnant
- People who are unlikely to cooperate with the trial, or who have a history of not following medical treatment plans
- People who have untreated psychological conditions or addiction issues
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +31650032165
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect of spinal cord stimulation (SCS) in patients with mononeuropathy as assessed by the perceived pain intensity.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.